BioVoice News March 2017 Issue 10 Volume 1 | Page 23

constantly reviewing the situation on daily basis . Infact , a few hospitals have been issued show cause notices besides raids as well . The well-known healthcare providers in New Delhi , Gurgaon , Faridabad and Lucknow have been directly asked to explain the reasons behind overcharging patients . The details on minute by minute actions by the NPPA are also being tweeted by its twitter handle . The same are also being provided to the minister as well .
Way forward
“ Time for this sector to fly like butterfly and the pharmaceutical and medical devices to be spun off as a separate ministry of pharmaceutical and medical devices . I have recommended this to the Prime Minister and this request is under active consideration by the PM and PMO ,” said the Union Minister for Chemicals and Fertilizer , Mr Ananth Kumar recently .
Notwithstanding the churning happening within it , the big day for domestic medical device industry has finally arrived . Having lived on the side-lines for years , the medical technology industry is one of the biggest opportunity areas in the bioscience sector . With number of patients having medical complications on rise , the growth could be gigantic if right policies are formulated at the right time . To boost ‘ Make in India ’ program and reduce import dependency , government has thus decided to include back medical device sector as one of the 25 flagship industry to steer the program . Rightly so , the government must now also try to rope in multinationals into the manufacturing plans . If they don ’ t want to participate , it would be their choice yet
government must act in a non-partisan manner .
There is a broader consensus on the need for a robust regulatory system for devices market . Yet it must be in sync with making available the maximum opportunity areas for all the stakeholders . Neither can we achieve excellence by shooing away global investors and companies nor by ignoring our own set of SMEs , indigenous innovators and new age startups . The middle ground for all players should be created for equal opportunities to all . The moot point is that we must build a big medical technology industry in India but also take all the stakeholders into confidence .
BIOVOICENEWS . COM 23